Discover B2B companies, suppliers, and manufacturers related to this keyword category
Making comprehensive liquid biopsy a reality
BioAro a proudly Canadian, biotechnology company focused on bringing personalized medicine to everyone.
MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases.
Leader in Immuno-Transcriptomic Precision Medicine solutions
Decoding cellular messengers to enable curative treatments for cancer
Detect cancer earlier with the power of circulating tumor methylated DNA (ctmDNA).
Personalized Genomics For A Healthier Future
Our goaI is to get you an easy-to-use, reliable and sensitive diagnostic test that can detect your biomarker of interest
Working to reduce the global burden of cancer with innovative diagnostics
Unleashing the Power of mRNA and AI for Cancer Diagnostics
Contribute to finding cures for cancer by being a leader in innovative research
We're impacting precision medicine with a first-in-class 🩸 liquid biopsy platform
Lighting the way with diagnostics
Rare cells analysis with single cell precision.
Delivering greater cfDNA, cfRNA and CTC yields for higher liquid biopsy test sensitivity and earlier cancer detection
Cancer profiling for precision oncology and early cancer detection
A leader in non-invasive genomics, early cancer diagnostics, biomarker & CDx
BioView improves cancer patients assessments and outcomes by providing novel automated imaging and analysis solutions
Molecular Genetics & Biotechnology
Leading developer of NGS technologies, including in cfDNA liquid biopsies for cancer diagnostic. Part of Exact Sciences.
Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic testing solutions.
We believe in empowering physicians with bold and innovative diagnostic solutions that may lead to better outcomes.
Localizing NGS testing to empower decisions across the entire healthcare journey for everyone, everywhere
The leading experts in cancer cell capture and analysis from liquid biopsies
Ultra-rare variants are detected with unparalleled sensitivity and specificity with TwinStrand Duplex Sequencing
Solving the health, wellness, and sustainable development challenges of our time
Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and management of cancer.
Karius is a life sciences company focused on saving lives from infectious diseases.
Democratizing Data-Driven Medicine, Together!
Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2025 & 2024 Top Workplaces Award Winner
To Know. To Act: Our mission is to save and improve lives through early, actionable, and personalized diagnoses.
Ultra-sensitive and multiplex nucleic acid assays for fast and cost efficient mutation detection in liquid biopsy
We are a liquid biopsy company that can rapidly evaluate cancer therapy response, resistance, and recurrence.
At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer.
Cancer precision medicine company developing exosome based liquid biopsy tests and drug delivery technologies
A French liquid biopsy technology dedicated to the isolation of circulating tumor cells (CTCs)
Advancing precision medicine through next-generation liquid biopsy oncology platform
Spatial is complicated. Let's make it simple.
A molecular diagnostics company dedicated to advancing the impact of genomics in healthcare and precision medicine.
Pioneering Non-Invasive Diagnostics with Liquid Biopsy
Detecting cancer before: we're building a platform to detect early-stage cancer using proprietary RNA sequencing methods